List view / Grid view
15 February 2017 | By Nicolás Giménez Stamminger, Manager IT Advisory, KPMG Switzerland
KMPG’s Nicolás Giménez Stamminger explains why serialisation is the solution to counterfeit medicines and how to implement a cost-effective serialisation strategy…
Intellectual Property (IP) is the lifeblood of the pharmaceutical industry. Without it, there would not be much of a business. Growing research and development globalisation, externalisation, the expansion of electronic data management systems and the lack of consistent global IP enforcement is increasing the capacity of external and internal parties…
14 June 2016 | By Victoria White, Digital Content Producer
The gang imported over 1.2 million unlicensed erectile dysfunction tablets and over 141,000 other illegal medicines including diazepam worth over £3.5 million...
25 April 2016 | By Victoria White, Digital Content Producer
New research is providing the foundation to apply criminology theory to preventing the production and sale of counterfeit medicines...
24 March 2016 | By Victoria White, European Pharmaceutical Review
We’ve created an infographic on counterfeit drugs, highlighting some of the actions taken to counter this global problem...
8 March 2016 | By Systech International
Global brands focus on consumer safety at Amsterdam conference...
16 October 2015 | By David Shore, Pfizer
Counterfeit medicines pose a serious risk to public health around the world. The trade in fake drugs is considerable; according to Pfizer’s own company records, more than 200 million counterfeit doses of Pfizer product have been intercepted since 2004. Meanwhile, the issue of counterfeits has no single or simple solution…
The World Health Organisation (WHO) in 2010 described counterfeit medicines as those which are “Deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and counterfeit products may include products with the correct ingredients or with the wrong ingredients, without active…
Confocal Raman Microscopy (CRM) is extremely useful for drug substance design, for patent infringement and counterfeit analysis.
15 September 2014 | By Issued on behalf of the IHMA by MHW PR Ltd
Millions of fakes pouring into EU, US and Japanese markets...
Counterfeit and substandard medicines have serious human health and economic costs...
